Mutagenesis and Molecular Modeling of the Orthosteric Binding Site of the mGlu2 Receptor Determining Interactions of the Group II Receptor Antagonist 3H‐HYDIA
Pharmaceutical Division, Discovery Research CNS and Medicinal Chemistry, F. Hoffmann‐La Roche Ltd., 4070 Basel (Switzerland), Fax: (+41)?61?6880382
Abstract:
Binding of the mGlu2/3 antagonist HYDIA in the closed conformation model of mGlu2 causes repulsive interactions with Y216 in lobe II of the binding pocket, preventing closure of the VFT.